reviewThe LancetSep 12, 2017HYBRID OA

After asthma: redefining airways diseases

University of Oxford · Oxford BioMedica (United Kingdom) · +35 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Momentum to the recent encouraging progress in new drug discovery and, as did the first asthma guidelines published 27 years ago, 14-17 lead to a decade or more of improved outcomes. We conclude the Commission with seven key recom mendations and summarise our views on how these could be developed to benefit patients with asthma (panel 1).

No related works found for this paper.

Funding